This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Universitè De Genève. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Inventor Spotlight: Catherine Gabrielle Zimmermann, Pioneer in Diagnostic Assays
Introduction: Catherine Gabrielle Zimmermann is an accomplished inventor based in Geneva, Switzerland. With her innovative approach to diagnostics, she has made significant contributions to the field of medicine, particularly in diagnosing transmissible spongiform encephalopathies (TSEs).
Latest Patents: Zimmermann holds a patent for a groundbreaking diagnostic assay for TSEs, specifically focusing on heart and brain fatty acid binding proteins (H-FABP, B-FABP). These proteins serve as markers for TSEs, including Creutzfeldt-Jakob disease (CJD). The invention leverages enzyme immunoassay techniques, utilizing specific antibodies to detect these markers. An important aspect of this invention is the ability to differentiate CJD from acute myocardial infarction (AMI) by employing other markers, such as troponin-1 or CK-MB.
Career Highlights: Catherine Gabrielle Zimmermann's career is marked by her dedication to research and innovation at the University of Geneva. Her work in developing diagnostic tools has garnered attention and recognition within the scientific community. As an inventor, she exemplifies the fusion of scientific knowledge and practical application, aiming to enhance disease diagnosis and patient care.
Collaborations: Throughout her career, Zimmermann has collaborated with notable scientists, including Denis Francois Hochstrasser and Jean-Charles Sanchez. These partnerships have fostered a dynamic research environment, enabling the development of cutting-edge diagnostic technologies and advancing their shared vision of improving healthcare.
Conclusion: Catherine Gabrielle Zimmermann is a trailblazer in the field of diagnostic assays, with her innovative patent contributing to the understanding and detection of serious medical conditions. Her work at the University of Geneva and collaborations with esteemed colleagues underscore her commitment to advancing medical science and improving diagnostic methods, ensuring a lasting impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile